Menu Back toBuilding on Opportunities from a Pandemic to Influence the Future of Clinical Research

DIA 2021 Global Annual Meeting

Building on Opportunities from a Pandemic to Influence the Future of Clinical Research

Session Chair(s)

Mat  Soukup, PhD

Mat Soukup, PhD

  • Deputy Director, Division of Biometrics VII, OB, OTS CDER
  • FDA, United States
Responding and adapting to the changes invoked by the COVID-19 pandemic on clinical research foster new opportunities in many aspects of clinical research. At the heart of these opportunities are the need for statistical and analytical innovation. This session will highlight several areas where statistical and analytical innovation have informed our response to the COVID-19 pandemic and what this means for the future of clinical research. There will be a talk on the use of artificial intelligence for the rapid identification and determination of potential therapeutics that have the best chance of treating against those infected with the SAR-COV-2 virus. Another talk will discuss how the COVID-19 pandemic has magnified the vulnerability and unsustainability of the current clinical development which emphasizes the need to move towards more pragmatic, patient-centric, and adaptive trial designs that make extensive use of computer technology. The final talk will discuss how analytics and data visualization foster an ability to make timely decisions that impact the healthcare sector and clinical development.
Learning Objective : Describe the immediate, and potential long-term, impact of the COVID-19 pandemic on the clinical-research enterprise, both in terms of trials in this disease as well as non-COVID-19 trials.


Mark  Lambrecht, PhD

Fighting COVID-19 with Trusted Analytics

Mark Lambrecht, PhD

  • Director, Global Health and Life Sciences Practice
  • SAS Institute Inc., Belgium
Marc E. Buyse, DrSc

Randomized Controlled Trials (RCTs): Lessons from COVID-19

Marc E. Buyse, DrSc

  • Chief Scientific Officer
  • IDDI, United States
Sherrine  Eid, MPH

Industry Update

Sherrine Eid, MPH

  • Health and Life Sciences Industry Consultant, SAS
  • SAS, United States